Investor's Business Daily on MSN
eBay, IBD stock of the day, keeps momentum with earnings beat
eBay stock is hovering near an entry after getting a strong response to its Q3 results, adding to a recent rally.
Investor's Business Daily on MSN
IBD 50 undergoes a big makeover. How changes will improve performance.
The IBD 50 has just gone through the biggest revision in its history.
Check Point Software Technologies ( CHKP) on Monday reported third-quarter earnings that met estimates while revenue and ...
In morning trades on the stock market today, SharkNinja stock jumped to an all-time high of 215.89. In recent trad ...
Rituximab has been linked to a higher risk of inflammatory bowel disease than other MS therapies. Explore what it means for ...
Spyre Therapeutics maintains a 'Strong Buy' rating, driven by promising IBD pipeline progress and robust cash reserves. Read ...
Gilead faces valuation headwinds as Medicare pricing and HIV reliance pressure grow. Read here for a detailed investment ...
Cantor Fitzgerald raised the firm’s price target on AbbVie (ABBV) to $325 from $290 and keeps an Overweight rating on the shares. AbbVie beat lowered Q3 ...
HS is a systemic disease with significant comorbidity, which complicates care. Dr. Lev-Tov argues that published guidelines and clear referral pathways make this burden manageable for dermatologists ...
InnoCare Pharma announced that the first subject has been dosed in the Phase 1 trial of ICP-B161, a bispecific antibody targeting TL1A and IL-23p19, for the potential treatment of autoimmune diseases, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results